Cipla all set to launch Favipiravir

An off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for treatment of COVID-19 patients, especially in mild and moderate cases

from moneyworks4me.com https://ift.tt/3fYpHNp
https://ift.tt/2WJCb3Y